Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

16.92B

Market cap16.92B

Price-Earnings ratio

19.42

Price-Earnings ratio19.42

Dividend yield

—

Dividend yield—

Average volume

1.70M

Average volume1.70M

High today

$87.00

High today$87.00

Low today

$85.06

Low today$85.06

Open price

$86.21

Open price$86.21

Volume

1.35M

Volume1.35M

52 Week high

$87.99

52 Week high$87.99

52 Week low

$53.56

52 Week low$53.56

INCY News

TipRanks 1d

Incyte price target raised to $104 from $90 at BofA

BofA analyst Tazeen Ahmad raised the firm’s price target on Incyte (INCY) to $104 from $90 and keeps a Buy rating on the shares. After having hosted the company...

Analyst ratings

50%

of 28 ratings

Buy

39.3%

Hold

50%

Sell

10.7%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.